Pasar al contenido principal

NUEVAS CONTRIBUCIONES FUNCIONALES DE BTK Y DGK-Z EN EL COMPORTAMIENTO Y LA RESPUESTA DE LOS LINFOCITOS B: IMPLICACIONES EN LINFOMAGENESIS E INMUNOTERAPIA

PID2021-125831OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Building the synapse engine to drive B lymphocyte function

  • Carrasco, Yolanda R.
B cell receptor (BCR)-mediated antigen-specific recognition activates B lymphocytes and drives the humoral immune response. This enables the generation of antibody-producing plasma cells, the effector arm of the B cell immune response, and of memory B cells, which confer protection against additional encounters with antigen. B cells search for cognate antigen in the complex cellular microarchitecture of secondary lymphoid organs, where antigens are captured and exposed on the surface of different immune cells. While scanning the cell network, the BCR can be stimulated by a specific antigen and elicit the establishment of the immune synapse with the antigen-presenting cell. At the immune synapse, an integrin-enriched supramolecular domain is assembled at the periphery of the B cell contact with the antigen-presenting cell, ensuring a stable and long-lasting interaction. The coordinated action of the actomyosin cytoskeleton and the microtubule network in the inner B cell space provides a structural framework that integrates signaling events and antigen uptake through the generation of traction forces and organelle polarization. Accordingly, the B cell immune synapse can be envisioned as a temporal engine that drives the molecular mechanisms needed for successful B cell activation. Here, I review different aspects of the B cell synapse engine and provide insights into other aspects poorly known or virtually unexplored., This work was supported by the Spanish Ministry of Science and Innovation, grant reference PID2021-125831OB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL

  • Polcik, Laura
  • Pethe, Abhishek
  • Ashok, Driti
  • Tissino, Erika
  • Fernández-Rego, Adrián
  • Pozzo, Federico
  • Danner, Danielle-Justine
  • Holst, Manuel
  • Martines, Claudio
  • Hofmann, Karin
  • Dimovski, Aleksandar J
  • Kissel, Sandra
  • Härzschel, Andrea
  • Li, Lixia
  • Bittolo, Tamara
  • Andrieux, Geoffroy
  • Haslauer, Theresa
  • Höpner, Jan Philip
  • Zaborsky, Nadja
  • Greil, Richard
  • Miething, Cornelius
  • Duque-Afonso, Jesus
  • Köhler, Natalie
  • Boerries, Melanie
  • Bomben, Riccardo
  • Duyster, Justus
  • Grosse, Robert
  • Gaidano, Gianluca
  • Zamò, Alberto
  • Zucchetto, Antonella
  • Carrasco, Yolanda R.
  • Efremov, Dimitar G
  • Gattei, Valter
  • Hartmann, Tanja Nicole
B-cell receptor (BCR) signaling is a key determinant of chronic lymphocytic leukemia (CLL) pathophysiology. CD49d, the α4 subunit of the very late antigen 4 integrin, can be activated by BCR signals; however, its role in modulating BCR functionality remains unknown. We used knockout mouse models and primary human CLL stratified by CD49d expression to address this aspect. CD49d was required for bone marrow (BM) infiltration and shaped BM infiltration patterns and patient outcomes in human CLL. In TCL1 transplantation models, the loss of CD49d abrogated BM homing and leukemic cell positioning within splenic niches. At the cellular level, CD49d-deficient murine TCL1 transgenic cells and human CD49d-low CLL cells failed to form efficient immune synapses with antigen-presenting membranes. Transcriptome analyses identified CD49d-dependent regulation of actin-associated pathways and distinct signatures of BCR responsiveness in both human and mouse cells. Consistently, CD49d-low human CLL cells displayed aberrant actin remodeling following BCR stimulation, and a second aggressive murine CLL model reproduced the actin and engraftment defects. Kinome profiling linked impaired antigen-induced BCR responses in CD49d-deficient murine cells to altered kinase activity, and pharmacologic actin perturbation phenocopied CD49d loss. In human CD49d-low CLL cells, a desynchronization of BCR-related downstream Syk and PLCɣ2 activation was found. Mechanistically, the CD49d-BCR interplay involved their colocalization, and CD49d converged with BCR signaling on a focal adhesion kinase-actin axis. In summary, our findings establish CD49d as a key regulator of BCR functionality in CLL, linking integrins to cytoskeletal dynamics and antigen responsiveness., The authors of this study are supported by Deutsche Krebshilfe (DKH) 70113993, 70116787 (T.N.H.), 70116490 (N.K.); the Deutsche Forschungsgemeinschaft (DFG) 437764364, 419090910 (T.N.H); José Carreras Leukemia Foundation DJCLS 04 R/2020 (T.N.H.), Bundesministerium für Bildung und Forschung (BMBF) 6LW0711 (T.N.H.), SFB-1479 – Project ID: 441891347-P03 (N.K.), CRC1160 (project ID 256073931-Z02) (M.B.), CRC/TRR167 (project ID 259373024-Z01) (M.B.), CRC1453 (project ID 431984000-S1) (M.B.), CRC1479 (project ID: 441891347- S1) (M.B.), TRR 359 (project ID 491676693-Z01) (M.B.), FOR 5476 UcarE (project ID 493802833-P7, M.B.), DFG under Germany’s Excellence Strategy (CIBSS - EXC 2189 – project ID 390939984) (N.K.); “Fill-in-the-gap scholarship” (L.P.); Forschungskommission der Medizinischen Fakultät Freiburg (T.N.H.); and the Mertelsmann Foundation MF2022007 (T.N.H.); Associazione Italiana Ricerca Cancro (AIRC), Investigator Grant IG-21687 (V.G.); Investigator Grant 2020 - 24566 (D.G.E); AIRC 5x1000 no. 21198, AIRC Foundation, Milan, Italy (G.G.); and PNRR-MAD-2022-12375673 (Next Generation EU, M6/C2_CALL 2022) (V.G.). A.F.R. is supported by an Formación de Personal Investigador contract from the Spanish Ministry of Science (PRE2021-098167). The IS studies were supported by PID2021-125831OB-I00 and funded by MCIN/AEI/10.13039/501100011033/ FEDER, UE (Y.R.C). They also acknowledge funding from the BMBF within the Medical Informatics Funding Scheme PM4Onco–FKZ 01ZZ2322A (M.B.) and EkoEstMed–FKZ 01ZZ2015 (G.A.)., Peer reviewed, Modelo experimental animal, Mam�feros - Roedores
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Diacylglycerol kinase ζ in B lymphocytes supports CD40-mediated immune synapse formation, mTORC1 signaling, and plasma cell fate

  • Fernández-Barrecheguren, Ana
  • Fernández-Rego, Adrián
  • Fuentes-Cantos, Lucía
  • Pons, Tirso
  • Estrada, Belén S
  • Iborra-Pernichi, Marta
  • de la Esperanza, María Velasco
  • Ebrahimi, Tahmineh
  • Sagrega-Aparisi, Ana
  • Cogliati, Sara
  • Martínez-Martín, Nuria
  • Jiménez-Saiz, Rodrigo
  • Carrasco, Yolanda R.
To mount a robust T cell-dependent immune response, antigen-specific B lymphocytes require the stimulation of the transmembrane receptor CD40 through immune synapse formation with CD4+ T follicular helper cells. CD40 stimulates the activation of mammalian target of rapamycin complex 1 (mTORC1) and remodels mitochondria to meet the increased bioenergetic and anabolic demands of activated B cells. Here, we found that diacylglycerol kinase ζ (DGKζ) supported mTORC1 activation downstream of CD40 stimulation in mouse B cells. We showed that DGKζ was required for organellar translocation to the CD40-mediated immune synapse and for the recruitment of mTORC1 to lysosomes, the latter of which was necessary for mTORC1 activation and function. The production of phosphatidic acid by DGKζ was crucial for these processes. DGKζ-/- B cells exhibited defects in protein biosynthesis, metabolite transporter expression, and cell cycle progression, together with dysregulation of the transcriptional network that determines B cell fate. To sustain their bioenergetic and metabolic demands, DGKζ-/- B cells enhanced their mitochondrial function. Together, these effects of DGKζ loss led to decreases in germinal center responses and in the generation of long-lived plasma cells and memory B cells in mice. Thus, our data identify DGKζ as an essential mediator of CD40 functions in the B cell immune response., A.F.-B. is funded by the Occident Foundation. A.F.-R. is supported by an FPI contract from the Spanish Ministry of Science (PRE2021-098167). Y.R.C. is supported by the grants PID2021-125831OB-i00 (founded by MCII/AEI/10.13039/501100011033/FEDER, UE) and PID2024-158193OB-i00 (founded by MCIU/AEI/10.13039/501100011033/FEDER, UE). R.J.-S. is supported by the Instituto de Salud Carlos III (CP20/00043; PI25/00477; RD24/0007/0037) and by grant CNS2024-154194 (founded by MCIN/AEI/10.13039/501100011033). S.C. is supported by grants PID2020-114054RA-i00 (founded by MCIN/AEI/10.13039/501100011033), CNS2023-143646 (founded by MICIU/AEI/10.13039/501100011033), and European Union NextGenerationEU/PRTR. B.S.E. is supported by an FPI contract from the Spanish Ministry of Science (PRE2022-102696). N.M.-M. is supported by grants CNS2022-135636, PID2021-126298OB-i00, and PID2024-162320OB-i00 (founded by MCIU/AEI/10.13039/501100011033/FEDER, UE) and HR22-00447 (founded by La Caixa)., Peer reviewed, Sin experimentacion animal ni uso de NAMs, in vitro - Tipos celulares
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

LRBA regulates actin cytoskeleton dynamics through NMIIA during B cell immune responses

  • Sindram, Elena
  • Montero-Hernández, Juan Eduardo
  • Frenger, Quentin
  • van Dijk, Hannah
  • Lang, Anna
  • Zeidler, Vanessa
  • Marsiske, Rebecca
  • Rhiel, Manuel
  • Geiger, Kerstin
  • Cornu, Tatjana I
  • Mace, Emily M
  • Spindler, Volker
  • Dengjel, Joern
  • Gros, Frédéric
  • Grimbacher, Bodo
  • Sepulveda, Fernando E
  • Carrasco, Yolanda R.
  • Andreani, Virginia
  • Gámez-Díaz, Laura
Patients with lipopolysaccharide-responsive beige-like anchor protein (LRBA) deficiency typically suffer from severe B cell dysfunction. However, the underlying mechanisms remain incompletely understood. In this study, we identify non-muscle myosin IIA (NMIIA) as an interaction partner of LRBA in B cells, and uncover a role for LRBA in regulating actin cytoskeleton dynamics during B cell activation. LRBA-deficient B cells exhibit abnormal migration, impaired F-actin polymerization, and reduced B cell receptor signalling and polarization upon activation. In addition, LRBA deficiency severely disrupts immune synapse formation as evidenced by diminished central SMAC formation, reduced microtubule organizing center translocation and disrupted BCR and lysosome polarization. Consistent with these defects, internalization of the BCR-antigen complex is also impaired. Mechanistically, NMIIA activation, assessed by myosin light chain (MLC) phosphorylation, is reduced in LRBA-deficient cells. In addition, LRBA co-localizes with active NMIIA during both migration and immune synapse formation. Collectively, our findings establish LRBA as an important regulator of cytoskeleton dynamics during B cell activation, which may contribute to the defective humoral immunity observed in LRBA-deficient patients., The Gámez-Díaz laboratory is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) (Project-ID 403222702 - SFB 1381), the EUCOR-Seed the Money Grant (ACTIv), the Hans A. Medical Scientist Programme, Faculty of Medicine, University of Freiburg and the Germany’s Excellence Strategy (CIBSS-EXC-2189, Project-ID 390939984). The Grimbacher laboratory is supported by the Deutsche Forschungsgemeinschaft (Project-ID GR1617/8-1), IMPATH-SFB (SFB1160/3 B5), RESIST-EXC-2155 – Project-ID 390874280, CIBSS–EXC-2189 – Project-ID 390939984; and GR 1617/17-1 - Project-D 519635399); the EU-funded PhD program IMMERGE (https://immergeproject.eu); the German Federal Ministry of Education and Research (BMBF) rare disease program (GAIN 01GM2206A); and the Wilhelm Sander-Stiftung (Förderantrags-Nr. 2023.115.1). The Lighthouse Core Facility is funded in part by the Medical Faculty, University of Freiburg (Project-ID 2021/B3-Fol) and the DFG (Project-ID 450392965). Fernando E Sepulveda received funding and support from the Agence Nationale de la Recherche (ANR-18-CE15-0017, ANR-22-CD17-0048, ANR-23-CE17-0022). The immune synapse studies were supported by the grant PID2021-125831OB-I00 founded by MCIN/AEI/10.13039/501100011033/FEDER, UE, to Yolanda R.Carrasco. This study was supported by the German Federal Ministry of Research, Technology and Space (BMFTR: CCR5 FKZ 01EK2205) to the Cornu Lab., Peer reviewed, Modelo experimental alternativo-NAM, in vitro - Tipos celulares